Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 198

1.

Differential kinetics and specificity of EBV-specific CD4+ and CD8+ T cells during primary infection.

Precopio ML, Sullivan JL, Willard C, Somasundaran M, Luzuriaga K.

J Immunol. 2003 Mar 1;170(5):2590-8.

2.

Reconstitution of EBV latent but not lytic antigen-specific CD4+ and CD8+ T cells after HIV treatment with highly active antiretroviral therapy.

Piriou E, Jansen CA, van Dort K, De Cuyper I, Nanlohy NM, Lange JM, van Oers MH, Miedema F, van Baarle D.

J Immunol. 2005 Aug 1;175(3):2010-7.

3.

Detailed kinetics of EBV-specific CD4+ and CD8+ T cells during primary EBV infection in a kidney transplant patient.

Piriou ER, van Dort K, Weel JF, Bemelman FJ, Gamadia LE, van Oers MH, van Baarle D.

Clin Immunol. 2006 Apr;119(1):16-20. Epub 2006 Jan 4.

PMID:
16386961
4.

Differential evolution and stability of epitope-specific CD8(+) T cell responses in EBV infection.

Catalina MD, Sullivan JL, Bak KR, Luzuriaga K.

J Immunol. 2001 Oct 15;167(8):4450-7. Erratum in: J Immunol 2001 Nov 15;167(10):6045.

5.

Clonal expansions in acute EBV infection are detectable in the CD8 and not the CD4 subset and persist with a variable CD45 phenotype.

Maini MK, Gudgeon N, Wedderburn LR, Rickinson AB, Beverley PC.

J Immunol. 2000 Nov 15;165(10):5729-37.

6.

Novel method for detection of virus-specific CD41+ T cells indicates a decreased EBV-specific CD4+ T cell response in untreated HIV-infected subjects.

Piriou ER, van Dort K, Nanlohy NM, van Oers MH, Miedema F, van Baarle D.

Eur J Immunol. 2005 Mar;35(3):796-805.

7.

Phenotypic and functional heterogeneity of EBV epitope-specific CD8+ T cells.

Catalina MD, Sullivan JL, Brody RM, Luzuriaga K.

J Immunol. 2002 Apr 15;168(8):4184-91.

8.

Defective control of latent Epstein-Barr virus infection in systemic lupus erythematosus.

Kang I, Quan T, Nolasco H, Park SH, Hong MS, Crouch J, Pamer EG, Howe JG, Craft J.

J Immunol. 2004 Jan 15;172(2):1287-94.

9.

Comparative immunophenotypic features of EBV-positive and EBV-negative atypical lymphocytosis.

Hudnall SD, Patel J, Schwab H, Martinez J.

Cytometry B Clin Cytom. 2003 Sep;55(1):22-8.

10.

Quantitative analysis of EBV-specific CD4/CD8 T cell numbers, absolute CD4/CD8 T cell numbers and EBV load in solid organ transplant recipients with PLTD.

Sebelin-Wulf K, Nguyen TD, Oertel S, Papp-Vary M, Trappe RU, Schulzki A, Pezzutto A, Riess H, Subklewe M.

Transpl Immunol. 2007 Apr;17(3):203-10. Epub 2006 Nov 29.

PMID:
17331848
11.

Recruitment during infectious mononucleosis of CD3+CD4+CD8+ virus-specific cytotoxic T cells which recognise Epstein-Barr virus lytic antigen BHRF1.

White CA, Cross SM, Kurilla MG, Kerr BM, Schmidt C, Misko IS, Khanna R, Moss DJ.

Virology. 1996 May 15;219(2):489-92.

13.

Differential targeting and shifts in the immunodominance of Epstein-Barr virus--specific CD8 and CD4 T cell responses during acute and persistent infection.

Woodberry T, Suscovich TJ, Henry LM, Davis JK, Frahm N, Walker BD, Scadden DT, Wang F, Brander C.

J Infect Dis. 2005 Nov 1;192(9):1513-24. Epub 2005 Sep 26.

PMID:
16206065
14.

The importance of exogenous antigen in priming the human CD8+ T cell response: lessons from the EBV nuclear antigen EBNA1.

Blake N, Haigh T, Shaka'a G, Croom-Carter D, Rickinson A.

J Immunol. 2000 Dec 15;165(12):7078-87.

15.

Epstein-Barr virus-specific CD8(+) T cells that re-express CD45RA are apoptosis-resistant memory cells that retain replicative potential.

Dunne PJ, Faint JM, Gudgeon NH, Fletcher JM, Plunkett FJ, Soares MV, Hislop AD, Annels NE, Rickinson AB, Salmon M, Akbar AN.

Blood. 2002 Aug 1;100(3):933-40.

16.

Detailed analysis of Epstein-Barr virus-specific CD4+ and CD8+ T cell responses during infectious mononucleosis.

Scherrenburg J, Piriou ER, Nanlohy NM, van Baarle D.

Clin Exp Immunol. 2008 Aug;153(2):231-9. doi: 10.1111/j.1365-2249.2008.03699.x. Epub 2008 Jun 28.

17.

Strong EBV-specific CD8+ T-cell response in patients with early multiple sclerosis.

Jilek S, Schluep M, Meylan P, Vingerhoets F, Guignard L, Monney A, Kleeberg J, Le Goff G, Pantaleo G, Du Pasquier RA.

Brain. 2008 Jul;131(Pt 7):1712-21. doi: 10.1093/brain/awn108. Epub 2008 Jun 11.

PMID:
18550621
18.

Antigen-driven expansion and contraction of CD8+-activated T cells in primary EBV infection.

Hoshino Y, Morishima T, Kimura H, Nishikawa K, Tsurumi T, Kuzushima K.

J Immunol. 1999 Nov 15;163(10):5735-40.

19.

Quantitative analysis of Epstein-Barr virus (EBV)-specific CD8+ T cells in patients with chronic active EBV infection.

Sugaya N, Kimura H, Hara S, Hoshino Y, Kojima S, Morishima T, Tsurumi T, Kuzushima K.

J Infect Dis. 2004 Sep 1;190(5):985-8. Epub 2004 Jul 23.

PMID:
15295706
20.

Clonotype selection and composition of human CD8 T cells specific for persistent herpes viruses varies with differentiation but is stable over time.

Iancu EM, Corthesy P, Baumgaertner P, Devevre E, Voelter V, Romero P, Speiser DE, Rufer N.

J Immunol. 2009 Jul 1;183(1):319-31. doi: 10.4049/jimmunol.0803647.

Supplemental Content

Support Center